Cargando…
Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling
BACKGROUND: Early diagnosis benefits lung cancer patients with higher survival, but most patients are diagnosed after metastasis. Although cell-free DNA (cfDNA) analysis holds promise, its sensitivity for detecting early-stage lung cancer is unsatisfying. We leveraged cfDNA fragmentomics to develop...
Autores principales: | Guo, Wei, Chen, Xin, Liu, Rui, Liang, Naixin, Ma, Qianli, Bao, Hua, Xu, Xiuxiu, Wu, Xue, Yang, Shanshan, Shao, Yang, Tan, Fengwei, Xue, Qi, Gao, Shugeng, He, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251329/ https://www.ncbi.nlm.nih.gov/pubmed/35780566 http://dx.doi.org/10.1016/j.ebiom.2022.104131 |
Ejemplares similares
-
Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma
por: Gao, Shugeng, et al.
Publicado: (2021) -
Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for stage I lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2022) -
Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection
por: Bao, Hua, et al.
Publicado: (2022) -
Early diagnosis of brain metastases using cerebrospinal fluid cell‐free DNA‐based breakpoint motif and mutational features in lung cancer
por: Qin, Xueting, et al.
Publicado: (2023) -
Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer
por: Wang, Siwei, et al.
Publicado: (2022)